DarioHealth (DRIO) Officer Reports 30,000 Restricted Share Award, Vesting in Two Years
Rhea-AI Filing Summary
Steven Nelson, President and CCO of DarioHealth Corp. (DRIO), reported a non-derivative acquisition on 09/11/2025 of 30,000 restricted shares granted at $0. The award vests on the last day of the second-year anniversary after the grant date. Following the transaction and a 20-for-1 reverse stock split effected on August 28, 2025, Nelson beneficially owns 34,750 shares. The Form 4 was signed on 09/15/2025.
Positive
- Officer alignment: President and CCO received a restricted share award, aligning his compensation with shareholder outcomes
- Clear vesting terms: Award vests on the last day of the second-year anniversary after grant, providing multi-year retention incentive
- Post-split ownership disclosed: Beneficial ownership figure reflects the 20-for-1 reverse stock split effected August 28, 2025
Negative
- None.
Insights
TL;DR: Senior officer received a restricted share award of 30,000 shares, vesting over two years; post-split beneficial ownership is 34,750 shares.
The filing documents a standard restricted share grant to an executive at no cash cost, which aligns management compensation with future performance through a multi-year vesting schedule. The post-transaction beneficial ownership number explicitly reflects a 20-for-1 reverse split enacted on August 28, 2025. No cash proceeds or derivative transactions are reported.
TL;DR: This is a routine insider grant with a defined vesting date; disclosure appears complete for the transaction reported.
The Form 4 identifies the reporting person, role, transaction date, award amount, vesting condition, and the effect of a recent reverse split. The signature and dates are present. The nature of the award and the explicit vesting schedule are disclosed consistent with Section 16 reporting requirements.